The book launch was attended by luminaries from the tech world, including Rekha Menon (Chairperson and Senior Managing Director at Accenture in India) and Nivruti Rai (Country Head, Intel India and VP & GM, Automotive Solutions Group, IFS at Intel Corporation)., , book launch, The Song of The Cell: An Exploration of Medicine and the New Human, kiran mazumdar-shaw, biocon, Dr Siddhartha Mukherjee, The Emperor of All Maladies: A Biography of Cancer, Immuneel Therapeutics
Omicron surging fast but also descends quickly: Kiran Mazumdar Shaw says heading towards Endemic - Shaw said that Omicron is surging fast but it also descends quickly, and lesser hospitalisation, lesser occupation of ICU beds are a huge relief.
Updated Jan 22, 2021 | 12:00 IST
Shares of Biocon saw a steep fall after the drugmaker s results missed analyst estimates in the quarter ended December. Net profit declined 19% year-on-year as expenses rose significantly. Biocon earnings | Photo Credit: BCCL
Key Highlights
Biocon says it continues to face headwinds across operational, regulatory and commercial function Dr. Christiane Hamacher steps down as the Managing Director of Biocon Biologics Limited due to professional differences with the Chairperson on strategic priorities and vision for the company
Mumbai: Biocon was one of the top laggards on Dalal Street today as the company declared it’s earnings, however, the earnings were a miss compared to the consensus street estimates that were pencilled in. Below are the key highlights of the earnings report by Biocon.
Infected? Still Take The Vaccine, Says Bharat Biotech Chairman
India is well prepared for distribution and Indian immunisation system is very robust, says Krishna Ella
PTI 23 December 2020 outlookindia.com 2020-12-23T19:29:56+05:30
Also read
People who are infected should also take a vaccine, and India is well prepared regarding the logistics for the vaccine distribution, Bharat Biotech Chairman & MD Krishna Ella said on Wednesday.
He was speaking in a virtual session on Sero surveillance significance in immunogenicity and safety in pre and post-vaccination era organised by industry body CII.
For the people who are infected, should they take a vaccine, the answer is yes , because they may not have a good T cells response. Ella said.